Human retinal progenitor cell therapy (jCyte)

N/A

Report date: 2025/04/17 17:53:17

Base Information

Drug NameHuman retinal progenitor cell therapy (jCyte)
Drug Alias NamejCellFamzeretcel
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Retinal progenitor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJcyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesJcyte IncSanten Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A